Subgroup analysis of any-grade CRS by target selection showed that any grade CRS was less frequent in the case of specific BCMA targeting (69.73%) compared to BCMA + CD19/dual BCMA targeting (89.78%) (interaction p < 0.05). Here, CD19 is linked to congenital rubella syndrome.